Literature DB >> 21468728

Rituximab in childhood lupus myocarditis.

Pooja Aggarwal, Surjit Singh, Deepti Suri, Amit Rawat, Nidhi Narula, Rohit ManojKumar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468728     DOI: 10.1007/s00296-011-1881-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  15 in total

1.  Lupus myocarditis in children.

Authors:  A Gupta; S Singh; R W Minz; B D Radotra; J Ahluwalia; A Grover
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

2.  Impairment of left ventricular diastolic function in systemic lupus erythematosus.

Authors:  Z Sasson; Y Rasooly; C W Chow; S Marshall; M B Urowitz
Journal:  Am J Cardiol       Date:  1992-06-15       Impact factor: 2.778

3.  B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.

Authors:  M J Leandro; G Cambridge; J C Edwards; M R Ehrenstein; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2005-09-27       Impact factor: 7.580

4.  Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus.

Authors:  Y Sherer; Y Levy; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

5.  Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases.

Authors:  M Naarendorp; L D Kerr; A S Khan; M H Ornstein
Journal:  J Rheumatol       Date:  1999-10       Impact factor: 4.666

6.  Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

Authors:  J-E Gottenberg; L Guillevin; O Lambotte; B Combe; Y Allanore; A Cantagrel; C Larroche; M Soubrier; L Bouillet; M Dougados; O Fain; D Farge; X Kyndt; O Lortholary; C Masson; B Moura; P Remy; T Thomas; D Wendling; J-M Anaya; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2004-11-18       Impact factor: 19.103

Review 7.  Cardiovascular manifestations of systemic lupus erythematosus: current perspective.

Authors:  A Ansari; P H Larson; H D Bates
Journal:  Prog Cardiovasc Dis       Date:  1985 May-Jun       Impact factor: 8.194

Review 8.  Myocarditis as a prognostic indicator in systemic lupus erythematosus.

Authors:  S Busteed; P Sparrow; C Molloy; M G Molloy
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

9.  [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].

Authors:  S Lehembre; A Macario-Barrel; P Musette; P Carvalho; P Joly
Journal:  Ann Dermatol Venereol       Date:  2006-01       Impact factor: 0.777

10.  Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis.

Authors:  Y K Chan; E K Li; L S Tam; L T C Chow; H K Ng
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

View more
  4 in total

1.  Lupus myocarditis receiving the rituximab therapy-a monocentric retrospective study.

Authors:  Chrong-Reen Wang; Yi-Shan Tsai; Wei-Ting Li
Journal:  Clin Rheumatol       Date:  2018-01-03       Impact factor: 2.980

2.  Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab.

Authors:  Adan Aftab; Nida Saleem; Syed Farhat Abbas; Zafar Ullah; Muhammad Haneef
Journal:  Case Rep Gastrointest Med       Date:  2022-06-06

3.  Pediatric Lupus Presenting as Pulmonary Hypertension, Myocarditis, and Massive Pericardial Effusion in an 11-Year-Old Girl: A Case Report and Literature Review.

Authors:  Yu-Jhen Chen; Ying-Jui Lin; Mindy Ming-Huey Guo
Journal:  Front Pediatr       Date:  2022-01-26       Impact factor: 3.418

4.  Lupus Myocarditis: A Case-Control Study from China.

Authors:  Li Zhang; Yan-Lin Zhu; Meng-Tao Li; Na Gao; Xin You; Qing-Jun Wu; Jin-Mei Su; Min Shen; Li-Dan Zhao; Jin-Jing Liu; Feng-Chun Zhang; Yan Zhao; Xiao-Feng Zeng
Journal:  Chin Med J (Engl)       Date:  2015-10-05       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.